市場調查報告書
商品編碼
1078169
乾燥症(修格蘭氏症候群)的全球市場:2022年~2028年Global Sjogren's syndrome Market 2022-2028 |
全球乾燥症(修格蘭氏症候群)的市場規模,在預測期間內預計以4.6%大幅度的年複合成長率成長。牽引市場的主要原因,是導致眼睛乾燥的隱形眼鏡的使用增加等。
本報告提供全球乾燥症(修格蘭氏症候群)市場相關調查分析,市場概要,各市場區隔的市場分析,各地區的市場分析,競爭情形,主要企業等相關的系統性資訊。
Global Sjogren Syndrome Market Size, Share & Trends Analysis Report By Type(Primary Sjogren's Syndrome, and Secondary Sjogren's Syndrome), by Drug Type (Pilocarpine, Cyclosporine, Hydroxychloroquine, and Immunosuppressive Agents)and by Test (Blood Test, Eye Test, Imaging Test, and Biopsy) Forecast Period (2022-2028)
The globalSjogren syndromemarket is anticipated to grow at a substantial CAGR of 4.6% during the forecast period.The market is mainly driven by a factor such as increased use of contact lenses which leads to dryness of the eyes. Moreover, high adoption of fast foods intakes with low calorie, vitamins, proteins, and nutritional values leads to unhealthy lifestyle adoption and that in turn become the enemy of immune diseases and the chance of growing Sjogren syndrome is increased and due to it the demand of the drugs and others treatments for this diseases Is also been increased.
The global Sjogren's syndromes market issegmented based ontype, drug type, and test. Based on type, the market is subdivided into primary sjogren's syndrome and secondary sjogren's syndrome. Based on a drug type, the market is sub-classified into pilocarpine, cyclosporine, hydroxychloroquine, and immunosuppressive agents. Based on thetest,the market is sub-segmented into blood tests, Eye tests, imaging tests, and biopsy.Among the test segment, the blood test sub-segment is expected to hold a prominent share in the market,as thesetests are routinely performed in the evaluation of a patient suffering from such Sjogren's syndrome as SS-A (Ro) and SS-B (La) antibodies, Antinuclear Antibody (ANA), Rheumatoid Factor, and others. Among all the Rheumatoid Factor Test is most commonly preferred due to RF being found in approximately half of the patients with the disease.
Geographically global Sjogren's syndromes market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.North American region is holding a prominent share owing to the growing number of autoimmune diseases that includes lupus, rheumatoid arthritis, dry mouth, and also increasing demand for advanced technological treatments solutions for these diseases. Moreover, increasing government initiatives in the region such as the North American Rheumatoid Arthritis Consortium has developed a plan to educate healthcare professionals and patients about the diagnosis and its treatment; attributed to such factors are contributing to the Sjogren's syndrome market growth in the region.
The major players that contribute to the growth of the global Sjogren's syndromesmarket include AbbVie Inc., Argentis Pharmaceuticals, LLC, AstraZeneca PLC, Bristol-Myers Squibb Co., Novartis International AG, Pfizer Inc., Sanofi S.A.,and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2021, Horizon Therapeutics plc. acquired Viela Bio, Inc. to Significantly Expand Development Pipeline Grow Rare Disease Medicine Portfolio, and Support Increased Scale Production. This agreement is mainly focused on autoimmune and severe inflammatory diseases in which companies will focus on UPLIZNA(autoimmune neuromuscular), VIB4920(Sjogren's syndrome and Phase 2), VIB7734(systemic lupus erythematosus), VIB1116(antibody for autoimmune diseases).
Research Methodology
The market study of the global Sjogren syndromemarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
Category-Pharmaceuticals